IP Library Granted Patent US 11,648,105
Granted Patent B2
US 11,648,105 · App. 16/302,411 · Granted May 16, 2023

Ophthalmological implant

Inventor: Arthur Meßner (Schnaittach, DE)
Assignee: HUMANOPTICS HOLDING AG
A61F2/15B29D11/00317B29D11/023A61F2240/002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,648,105
App. No.
16/302,411
Granted
May 16, 2023
Kind
B2
Abstract

An ophthalmological implant includes a main structure with a central aperture, a first side, and a second side arranged opposite the first side. It further includes a plurality of pigment arrangements arranged in the main structure, at least one of the pigment arrangements includes at least one color pigment and an enclosure that encloses at least most of the at least one color pigment.

Claims (32)

1. An ophthalmological implant, comprising:

a main structure comprising a central aperture, a first side and a second side arranged opposite the first side, the main structure having a thickness between 0.1 mm and 0.4 mm; and

a plurality of pigment arrangements arranged in the main structure, wherein each of the pigment arrangements has an inner color pigment and an outer enclosure completely enclosing the color pigment, the enclosure of each pigment arrangement having an enclosure outer shape, at least one color pigment of the each pigment arrangement has a color pigment outer shape, wherein the enclosure outer shape corresponds to the color pigment outer shape of the at least one color pigment of each pigment arrangement;

a material of the enclosures being harder than a material of the main structure;

the enclosures having a uniform enclosure thickness;

the main structure having a thickness which is between 0.1 mm and 0.4 mm.

2. An ophthalmological implant as claimed in claim 1 , wherein the material of the main structure and the material of the enclosures are configured to yield to a tool adapting the ophthalmological implant, the material of the enclosures being biocompatible material.

3. An ophthalmological implant as claimed in claim 1 , wherein the enclosures have an enclosure thickness, which is smaller than a dimension of the color pigment of a respective pigment arrangement.

4. An ophthalmological implant as claimed in claim 1 , wherein the enclosures have an enclosure thickness, which is between 0.1 μm and 10 μm in each case.

5. An ophthalmological implant as claimed in claim 1 , wherein the enclosures have biocompatible material.

6. An ophthalmological implant as claimed in claim 1 , wherein the enclosures comprise reactive monomers.

7. An ophthalmological implant as claimed in claim 6 , wherein the reactive monomers are provided on an outside of the enclosures.

8. An ophthalmological implant as claimed in claim 1 , wherein each of the plurality of pigment arrangements has a circumferential diameter less than 30 μm.

9. An ophthalmological implant as claimed in claim 1 , wherein the plurality of pigment arrangements are arranged in at least one layer of the main structure.

10. An ophthalmological implant as claimed in claim 1 , wherein the plurality of pigment arrangements are arranged such the plurality of pigment arrangements at least partly overlap each other.

11. An ophthalmological implant as claimed in claim 1 , wherein the main structure is formed by a main structure material and the enclosures are formed by an enclosure material, wherein the main structure material and the enclosure material differ from one another.

12. An ophthalmological implant as claimed in claim 1 , wherein the color pigment is harder than the material of the main structure.

13. An ophthalmological implant as claimed in claim 1 , wherein the main structure has a multi-ply design.

14. An ophthalmological implant as claimed in claim 1 , wherein each of the plurality of pigment arrangements has a circumferential diameter less than 10 μm.

15. An ophthalmological implant, comprising:

a main structure comprising a central aperture, a first side and a second side arranged opposite the first side; and

a plurality of pigment arrangements arranged in the main structure, wherein each of the pigment arrangements has an inner color pigment and an outer enclosure completely enclosing the inner color pigment, each of the enclosures having an enclosure thickness, which is between 0.1 μm and 10 μm in each case;

a material of the enclosures being harder than a material of the main structure;

the enclosures having a uniform enclosure thickness;

the main structure having a thickness which is between 0.1 mm and 0.4 mm.

16. An ophthalmological implant, comprising:

a main structure comprising a central aperture, a first side and a second side arranged opposite the first side, the main structure having a thickness which is between 0.1 mm and 0.4 mm; and

a plurality of pigment arrangements arranged in the main structure, wherein each of the pigment arrangements is separate, and has an inner color pigment and an outer enclosure individually and completely enclosing the respective inner color pigment, a material of the enclosure being harder than a material of the main structure, the enclosures having a uniform enclosure thickness, each of the plurality of pigment arrangements having a circumferential diameter less than 30 μm.

17. An ophthalmological implant in accordance with claim 16 , wherein:

the material of the main structure and the material of the enclosures are configured to arrange each of the plurality of pigment arrangements displaceable in the main structure when reducing a size of the ophthalmological implant, the material of the enclosure being biocompatible material.

18. An ophthalmological implant in accordance with claim 16 , wherein:

the material of the main structure and the material of the enclosures are configured to cause the plurality of pigment arrangements to yield to a reduction tool when reducing a size of the ophthalmological implant, the material of the enclosure being biocompatible material, each of the plurality of pigment arrangements being separate from each other in the material of the main structure.

Assignments (2)
MERGER Recorded Jul 15, 2022
From: HUMANOPTICS AG
To: HUMANOPTICS HOLDING AG
Reel/Frame 060678/0027 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2019
From: MESSNER, ARTHUR, DR.
To: HUMANOPTICS AG
Reel/Frame 049580/0536 →
Priority Claims (1)
DE 10 2016 208 395.3 · May 17, 2016 · national
Continuity (1)
Related Publication 20190201187A1 · Jul 4, 2019